Prognostic value of microRNA-495-3p, adiponectin, and cardiometabolic index in type 2 diabetic nephropathy

Table 1 Baseline information, mean ± SD/n (%)

Variables		Control (n = 49)	Study (n = 98)	χ2/t value	P value
Age (years)		46.01 ± 6.18	45.89 ± 4.13	-0.140	0.889
Gender	Male	20 (40.82)	42 (42.86)	0.056	0.813
	Female	29 (59.18)	56 (57.14)
BMI (kg/m2)		25.11 ± 2.15	25.41 ± 2.18	0.790	0.431
Smoking	Yes	12 (24.49)	23 (23.47)	0.019	0.891
	No	37 (75.51)	75 (76.53)
Duration of disease (years)		5.23 ± 1.16	5.11 ± 1.03	-0.638	0.524
Drinking	Yes	16 (32.65)	30 (30.61)	0.063	0.801
	No	33 (67.35)	68 (69.39)
Serum creatinine (μmol/L)		65.15 ± 7.15	115.26 ± 30.16	-11.452	< 0.001
24-hour urinary protein quantification (mg/24 hours)		226.21 ± 21.05	521.15 ± 45.26	-43.280	< 0.001
Urinary albumin-to-creatinine ratio (mg/g)		21.02 ± 2.65	44.26 ± 5.12	-29.805	< 0.001

BMI: Body mass index.